Cargando…
Impact of global PTP1B deficiency on the gut barrier permeability during NASH in mice
OBJECTIVE: Non-alcoholic steatohepatitis (NASH) is characterized by a robust pro-inflammatory component at both hepatic and systemic levels together with a disease-specific gut microbiome signature. Protein tyrosine phosphatase 1 B (PTP1B) plays distinct roles in non-immune and immune cells, in the...
Autores principales: | Rubio, Carmen, Puerto, Marta, García-Rodríquez, Juan J., Lu, Van B., García-Martínez, Irma, Alén, Rosa, Sanmartín-Salinas, Patricia, Toledo-Lobo, M. Val, Saiz, Jorge, Ruperez, Javier, Barbas, Coral, Menchén, Luis, Gribble, Fiona M., Reimann, Frank, Guijarro, Luis G., Carrascosa, Jose M., Valverde, Ángela M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082558/ https://www.ncbi.nlm.nih.gov/pubmed/32244182 http://dx.doi.org/10.1016/j.molmet.2020.01.018 |
Ejemplares similares
-
Insulin receptor substrate 2 (IRS2) deficiency delays liver fibrosis associated with cholestatic injury
por: Villar-Lorenzo, Andrea, et al.
Publicado: (2019) -
Overexpression of IRS-4 Correlates with Procaspase 3 Levels in Tumoural Tissue of Patients with Colorectal Cancer
por: Sanmartín-Salinas, Patricia, et al.
Publicado: (2018) -
Efficacy and safety of endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy in obese subjects with Non-Alcoholic SteatoHepatitis (NASH): study protocol for a randomized controlled trial (TESLA-NASH study)
por: Lavín-Alconero, Lucía, et al.
Publicado: (2021) -
Differential Effects of a Glucagon-Like Peptide 1 Receptor Agonist in Non-Alcoholic Fatty Liver Disease and in Response to Hepatectomy
por: Valdecantos, M. Pilar, et al.
Publicado: (2018) -
Insights Into Extracellular Vesicles as Biomarker of NAFLD Pathogenesis
por: Garcia-Martinez, Irma, et al.
Publicado: (2020)